– ASRT / Zydus Lifesciences filed delisting notice, closing June 16
– ESPR / ARCHIMED cleared Germany
– ORLA / EQX cleared Competition Canada
– GTWO.to / GMIN.to announced Glass Lewis recommends vote For
– WBD / SPKY cleared ACCC
– KSI.to / Thoma Bravo set July 30 vote
– AVNS / American Industrial Partners set July 22 vote
– RAMP / PUB set Aug 17 vote
– KW vote
– KALV tender expires

– QRED announced a business combination with Robseek
– LEGT / ENRD deal closed, 16.6 million shares (98.3%) redeemed, 295k shares remain
– FGMC stockholders approved BOXABL deal
– SHOTU $200 million IPO
– JABU $150 million IPO
– AVAC filed S-1 for $100 million IPO
– PGAC stockholders approved deadline extension to June 6 2027, no redemption figures given
– PCSC extension vote
– MLAC redemption
– ALF redemption
– APURU split

– NUVL to be acquired by GSK for $124.00 cash per share, 40.1% premium, $9.4 billion
– CPRX / Angelini Pharma filed DEFM14a, vote July 8, closing Q3 2026
– WBD / PSKY / UK CMA phase 1 launched
– XOMA / LGND filed S-4/a, vote July 13, closing Q3 2026
– RUP vote

– ISNRU $200 million IPO
– OCACU $100 million IPO
– VACH / VRXA deal closed
– CGCFU filed S-1 for $250 million IPO
– APBDU filed S-1 for $135 million IPO
– RACD filed S-1 for $75 million IPO
– GRAF filed DEF14a to extend deadline to Sept 27 2026, vote June 26, NAV $10.83
– FGMC deal vote
– FSHP redemption